Since IDH1/H2 and TP53 mutations are found in a large percentage of HCC patients,31 we further analyzed the correlation between IDH1, IDH2, and p53 mutations and the expression of EPDR1 in HCC using TCGA database (Figure S4). This evidence concerns the gene IDH2 and hepatocellular carcinoma.